These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
120 related items for PubMed ID: 221395
21. [Studies on Epstein-Barr virus (EBV) infection and reactivity of peripheral B lymphocytes to EBV in patients with ataxia telangiectasia]. Okano M. Hokkaido Igaku Zasshi; 1986 Jul; 61(4):584-92. PubMed ID: 3019855 [Abstract] [Full Text] [Related]
22. Epstein-Barr virus antibodies in patients with ataxia-telangiectasia and other immunodeficiency diseases. Joncas JH, Wills A, Reece E, Fox Z. Can Med Assoc J; 1981 Oct 15; 125(8):845-9. PubMed ID: 6272957 [Abstract] [Full Text] [Related]
23. Epstein-Barr virus-infected B cells expanding in germinal centers of infectious mononucleosis patients do not participate in the germinal center reaction. Kurth J, Hansmann ML, Rajewsky K, Küppers R. Proc Natl Acad Sci U S A; 2003 Apr 15; 100(8):4730-5. PubMed ID: 12665622 [Abstract] [Full Text] [Related]
24. Disease-related differences in antibody patterns against EBV-encoded nuclear antigens EBNA 1, EBNA 2 and EBNA 6. Lennette ET, Rymo L, Yadav M, Masucci G, Merk K, Timar L, Klein G. Eur J Cancer; 1993 Apr 15; 29A(11):1584-9. PubMed ID: 8217366 [Abstract] [Full Text] [Related]
25. Restricted low-level human antibody responses against Epstein-Barr virus (EBV)-encoded latent membrane protein 1 in a subgroup of patients with EBV-associated diseases. Meij P, Vervoort MB, Aarbiou J, van Dissel P, Brink A, Bloemena E, Meijer CJ, Middeldorp JM. J Infect Dis; 1999 May 15; 179(5):1108-15. PubMed ID: 10191211 [Abstract] [Full Text] [Related]
26. Epstein-barr-virus nuclear antigen. Vonka V, Hirsch I. Prog Med Virol; 1982 May 15; 28():145-79. PubMed ID: 6283600 [No Abstract] [Full Text] [Related]
27. Immunological characterization of Hodgkin's and non-Hodgkin's lymphoma patients with high antibody titers against Epstein-Barr virus-associated antigens. Masucci G, Mellstedt H, Masucci MG, Szigeti R, Ernberg I, Björkholm M, Tsukuda K, Henle G, Henle W, Pearson G. Cancer Res; 1984 Mar 15; 44(3):1288-300. PubMed ID: 6318984 [Abstract] [Full Text] [Related]
28. The biology of circulating B lymphocytes infected with Epstein-Barr virus during infectious mononucleosis. Robinson JE. Yale J Biol Med; 1982 Mar 15; 55(3-4):311-6. PubMed ID: 6295008 [Abstract] [Full Text] [Related]
29. Plasmacytic differentiation of circulating Epstein-Barr virus-infected B lymphocytes during acute infectious mononucleosis. Robinson JE, Smith D, Niederman J. J Exp Med; 1981 Feb 01; 153(2):235-44. PubMed ID: 6264016 [Abstract] [Full Text] [Related]
30. Epstein--Barr virus nuclear antigen in a non-Hodgkin's lymphoma. Slovin SF, Nichols WS. Cancer Invest; 1984 Feb 01; 2(1):21-6. PubMed ID: 6322937 [Abstract] [Full Text] [Related]
31. Antibodies to a new antigen induced by Epstein-Barr virus in patients with nasopharyngeal carcinoma, leukemia, malignant lymphoma, and in control groups. Ida S, Sairenji T, Hinuma Y. Gan; 1972 Feb 01; 63(1):49-55. PubMed ID: 4339712 [No Abstract] [Full Text] [Related]
32. Inhibition of Epstein-Barr virus transformation: evidence for a block between EBNA production and cell proliferation. Pope JH, Moss DJ. IARC Sci Publ (1971); 1978 Feb 01; (24 Pt 2):617-22. PubMed ID: 221385 [Abstract] [Full Text] [Related]
33. Epstein-Barr virus in a CD8-positive T-cell lymphoma. Richel DJ, Lepoutre JM, Kapsenberg JG, Ooms EC, Boom WR, Boucher CA, Kluin PM. Am J Pathol; 1990 May 01; 136(5):1093-9. PubMed ID: 2161617 [Abstract] [Full Text] [Related]
34. B cells under influence: transformation of B cells by Epstein-Barr virus. Küppers R. Nat Rev Immunol; 2003 Oct 01; 3(10):801-12. PubMed ID: 14523386 [Abstract] [Full Text] [Related]
35. Mitotic EBNA-positive lymphocytes in peripheral blood during infectious mononucleosis. Robinson J, Smith D, Niederman J. Nature; 1980 Sep 25; 287(5780):334-5. PubMed ID: 6252472 [Abstract] [Full Text] [Related]
36. Epstein-barr virus-associated non-Hodgkin's lymphoma of B-cell origin, Hodgkin's disease, acute leukemia, and systemic lupus erythematosus: a serologic and molecular analysis. Mitarnun W, Pradutkanchana J, Takao S, Saechan V, Suwiwat S, Ishida T. J Med Assoc Thai; 2002 May 25; 85(5):552-9. PubMed ID: 12188384 [Abstract] [Full Text] [Related]
37. Effect of different Epstein-Barr virus-determined antigens (EBNA, EA, and VCA) on the leukocyte migration of healthy donors and patients with infectious mononucleosis and certain immunodeficiencies. Szigeti R, Masucci MG, Henle W, Henle G, Purtilo D, Klein G. Clin Immunol Immunopathol; 1982 Jan 25; 22(1):128-38. PubMed ID: 6288294 [No Abstract] [Full Text] [Related]
38. Epstein-Barr virus latent membrane protein expression by Hodgkin and Reed-Sternberg-like cells in acute infectious mononucleosis. Isaacson PG, Schmid C, Pan L, Wotherspoon AC, Wright DH. J Pathol; 1992 Jul 25; 167(3):267-71. PubMed ID: 1381432 [Abstract] [Full Text] [Related]
39. B-cell polyclonal activation and Epstein-Barr viral abortive lytic cycle are two key features in acute infectious mononucleosis. Al Tabaa Y, Tuaillon E, Jeziorski E, Ouedraogo DE, Bolloré K, Rubbo PA, Foulongne V, Rodière M, Vendrell JP. J Clin Virol; 2011 Sep 25; 52(1):33-7. PubMed ID: 21684200 [Abstract] [Full Text] [Related]
40. Phenotype and frequency of Epstein-Barr virus-infected cells in pretreatment blood samples from patients with Hodgkin lymphoma. Khan G, Lake A, Shield L, Freeland J, Andrew L, Alexander FE, Jackson R, Taylor PR, McCruden EA, Jarrett RF. Br J Haematol; 2005 May 25; 129(4):511-9. PubMed ID: 15877733 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]